Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7695 USD | -3.26% | -3.45% | +34.34% |
May. 13 | Transcript : Vaxart, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
May. 13 | Vaxart, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
136M | - | - | - | |||
124B | ||||||
109B | ||||||
23.84B | - | |||||
22.42B | - | |||||
17.5B |
- Stock Market
- Equities
- VXRT Stock
- Charts Vaxart, Inc.
- Sector Chart